GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
Interesting Engineering on MSN
OpenAI partners with US govt for bio-weapons detection and threat preparedness
OpenAI has launched a new biodefense initiative centered on GPT-Rosalind, a specialized frontier-reasoning AI ...
OpenAI has expanded access to its upgraded GPT-Rosalind AI model, designed to help researchers accelerate drug discovery, ...
Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering.
AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...
April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as the startup deepens its push into the life ...
Shares of leading life sciences companies will be in focus on Friday after OpenAI launched GPT-Rosalind, an AI model designed to accelerate drug discovery and support biology-related research work. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results